Today’s episode of Lung Cancer Considered is part of our special series on seminal trials in thoracic oncology, focusing on the phase I study of the PD-1 inhibitor nivolumab. Hosts Dr. Narjust Florez and Dr. Stephen Liu discuss that study with guest Dr. Julie Brahmer from Johns Hopkins University. This podcast features surprise guest interviews with several doctors who were mentored by Dr. Brahmer.

Seminal Trials: Nivolumab Phase I Trial & Immunotherapy for NSCLC

When the world is full of distractions, and you desperately need to sleep, study, focus or soothe a baby, this fan sound blocks out those noisy distractions. Create a calming ambience with the fan white noise.

10 hour version on YouTube: https://www.youtube.com/watch?v=NB6X0xbSbvU
purchase mp3: https://relaxingwhitenoise.com/products/fan-noise-for-sleeping-mp3

Check out our Sleep Sound Playlist for more fan sounds: 
soundcloud.com/relaxing-white-noise/sets/sleep-sounds

DISCLAIMER: Remember that loud sounds can potentially damage your hearing. When playing one of our videos, if you cannot have a conversation over the sound without raising your voice, the sound may be too loud for your ears. Please do not place speakers right next to a baby’s ears. If you have difficulty hearing or hear ringing in your ears, please immediately discontinue listening to the white noise sounds and consult an audiologist or your physician. The sounds provided by this Youtube channel are for entertainment purposes only and are not a treatment for sleep disorders or tinnitus. If you have significant difficulty sleeping on a regular basis, experience fitful/restless sleep, or feel tired during the day, please consult your physician.

© Relaxing White Noise LLC, 2018. All rights reserved. Any reproduction or republication of all or part of this text/visual/audio is prohibited.

Fan Noise for Sleeping (75 Minutes)

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by AstraZeneca, Genentech, Daiichi Sankyo, Inc., and Takeda

Seminal Trials: Nivolumab Phase I Trial & Immunotherapy for NSCLC

Lung Cancer Considered

Related tracks